This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chinese Academy of Sciences, The Garvan Institute of Medical Research, Australia. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,346 
1 out of 1 Years Active: 2014
Title: **Jiming Ye: Pioneering Innovations in Diabetes and Obesity Treatment**
Introduction
Jiming Ye, an accomplished inventor based in Sydney, Australia, has made significant contributions to the field of medicine. With a focus on the prevention and treatment of diabetes and obesity, Ye's work reflects a commitment to advancing healthcare through innovative research and inventions.
Latest Patents
Jiming Ye holds a patent that discloses a medical use of cucurbitane triterpenoids isolated from the Cucurbitaceae family. This invention plays a crucial role in the preparation of medications aimed at preventing and treating diabetes and obesity. The cucurbitane triterpenoids serve as glucose uptake stimulators and act as agonists for the translocation of glucose transporter 4 (GLUT4) to the cell membrane. Additionally, they activate adenosine monophosphate-activated protein kinase (AMPK), showing promise in the management of glucose levels and metabolic health.
Career Highlights
Throughout his career, Jiming Ye has been associated with prestigious organizations such as the Shanghai Institute of Materia Medica and the Chinese Academy of Sciences. His role at The Garvan Institute of Medical Research in Australia has further solidified his expertise in medical research, particularly concerning diabetes and obesity.
Collaborations
Jiming Ye has collaborated with notable coworkers like Yang Ye and Minjia Tan. Through these partnerships, they have contributed to groundbreaking research and development in their respective fields, enhancing the understanding of metabolic diseases and the potential therapeutic applications of natural compounds.
Conclusion
Jiming Ye's innovative work in the medical field demonstrates the impact that focused research and development can have on addressing significant health challenges like diabetes and obesity. His patent on cucurbitane triterpenoids not only showcases his inventive spirit but also provides a foundation for future advancements in treatment options. As researchers and inventors like Jiming Ye continue to explore new possibilities, the future of diabetes and obesity management looks promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile